DIA selects Basel to host 30th EuroMeeting
The Drug Information Association (DIA) has chosen Basel in Switzerland as the location for the 30th anniversary of its EuroMeeting in 2018. The event will take place from 17 to 19 April.
The congress will focus on increased collaboration between the regulatory and the health technology assessment (HTA) / payer environment, and to reflect this area of increasing importance, a new steering committee structure, according to DIA.
The central themes for the EuroMeeting will include:
- Can regulators and HTA bodies create synergies for patient access?
- What are necessary steps towards outcome-driven health systems?
- Medicines of the future: what will innovation need and bring?
- How can better outcomes be enabled by big data?
- What is the future of pharmacovigilance?
- What can stakeholders expect from clinical trial (development), transparency and medical information?
- A new era for medical devices and diagnostics. How is the impact?
- Drug development and regulatory approval - reference points around the globe or globalization?
- How can we enable clinical research in Europe further?
- Can new health economic models increase access to innovation and attractiveness for bioventures and investors?
The co-chairs for the 2018 EuroMeeting are Luca Pani, from the European Medicines Agency in London, and Michelle Rohrer, global head of product development regulatory & policy at Roche in Basel.
The deadline for submission of abstracts is 26 June 2017.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
